Valbenazine Safe and Effective for Long-Term Treatment of Tardive ...
Apr 29, 2025 · A published paper pooling the KINECT-3 extension (NCT02274558) and KINECT-4 (NCT02405091) studies of valbenazine (Ingrezza; Neurocrine Biosciences) revealed that the therapy …
New Ingrezza Data Demonstrates Functional and Quality of Life ...
May 16, 2025 · Key Takeaways Valbenazine (Ingrezza) significantly improves health-related quality of life in tardive dyskinesia patients, enhancing mobility, self-care, and reducing pain and anxiety. …
Improvement in Quality of Life and Functional Status Following ...
Apr 7, 2025 · Background: TD significantly impacts quality of life (QoL) beyond movement symptoms. A web-based survey and chart extraction among US physicians, nurse practitioners, and physician …
Valbenazine Phase 3 Study Confirms Safety, Efficacy for ... - MedCentral
Jun 4, 2024 · Valbenazine can be a safe, tolerable, and highly effective long-term treatment option for people with tardive dyskinesia (TD), according to the results of a post hoc study led by manufacturer …
Safety and efficacy of valbenazine for the treatment of chorea ...
The positive results provide evidence for valbenazine as an effective and well tolerated potential treatment option for patients with chorea associated with Huntington's disease.
Valbenazine (Ingrezza): The First FDA-Approved Treatment for …
Chemical Structure Of Valbenazine 14 MECHANISM OF ACTION Valbenazine’s mechanism of action is mediated through the reversible inhibition of VMAT2 in the treatment of TD. 14 VMAT2 is selective to …
Comparative Analysis of Deutetrabenazine and Valbenazine as VMAT2 ...
The valbenazine studies showed favorable results in reducing TD symptoms and were well-tolerated. Discussion: The studies reviewed in this analysis underscore the potential of deutetrabenazine and …
Improvements Over Time with Valbenazine in Elderly Adults (≥65 …
Apr 23, 2025 · In elderly adults who received up to 48 weeks of treatment, long-term valbenazine treatment led to substantial and sustained improvements in tardive dyskinesia according to clinician …
Sustained Improvements with Once-daily Valbenazine in Chorea …
Apr 9, 2024 · Conclusions: In these interim analyses of KINECT-HD2, long-term treatment with once-daily valbenazine was well tolerated and provided clinically meaningful improvement in chorea …
A systematic review on treatment of tardive dyskinesia with valbenazine …
May 20, 2019 · Current evidence-based recommendations determine an unmet need for efficacious treatment of TD. This systematic review was planned to update the evidence for TD treatment, …